Bio Farma, a state-owned and sole vaccine and anti-sera manufacturer in Indonesia, has, since its establishment in 1890, played an important role in supporting global health through the provision of vaccines both nationally as well as global. As one of a few WHO prequalified vaccine manufacturers, Bio Farma strives to “Dedicate to improve Quality of Life”. Expanding its product portfolio to other life science products, Bio Farma continues to engage in research activities collaborating with numerous prominent national as well as international partners.

www.biofarma.co.id



We would like to thank to RSUP dr. Soeradji Tirtonegoro hospital for collaborating in allowing us to use their clinical trial as an authentic case. For data integrity and training purposes, all records are modified.

http://rsupsoeradji.id/